Home > Neuropace Salary

Neuropace Salary

  • 15
  • 64
  • 64
Neuropace average salary is $186,398, median salary is $186,398 with a salary range from $177,200 to $195,596.
Neuropace salaries are collected from government agencies and companies. Each salary is associated with a real job position. Neuropace salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
177,200
Average
186,398
Median
186,398
High
195,596
Total 3 Neuropace Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Physician 195,596-195,596 Helena, AR, 72342 2017 Neuropace Physician Salaries (3)
Neuropace Helena, AR Salaries
Physician 177,200-177,200 Helena, AR, 72342 2014 Neuropace Physician Salaries (3)
Neuropace Helena, AR Salaries
Family Practice Physician 177,200-177,200 Helena, AR, 72342 2014 Neuropace Family Practice Physician Salaries (1)
Neuropace Helena, AR Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Neuropace salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Neuropace Jobs
See more Neuropace Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Neuropace... Information
  • NeuroPace Inc
  • Industry: Medical Equipment
  • City: Mountain View, CA
  • NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide. Patients are currently being enrolled in a clinical trial of the company's Responsive Neurostimulator (RNS?) system for treating medically refractory epilepsy.